{"id":12678,"date":"2025-07-10T09:16:47","date_gmt":"2025-07-10T13:16:47","guid":{"rendered":"https:\/\/www.rigicon.com\/glossary-term\/prostate-screening-medical-glossary-entry\/"},"modified":"2026-10-06T12:50:55","modified_gmt":"2026-10-06T16:50:55","slug":"rastreamento-prostatico","status":"publish","type":"glossary-term","link":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/","title":{"rendered":"Rastreamento Prost\u00e1tico"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","glossary-category":[136],"glossary-product":[104,105],"class_list":["post-12678","glossary-term","type-glossary-term","status-publish","hentry","glossary-category-prostate-cancer-diagnostics","glossary-product-infla10-pulse-ipp-series","glossary-product-rigi10-malleable-penile-prosthesis"],"acf":{"gt-definition":"<p>O rastreamento prost\u00e1tico refere-se ao processo de testar homens assintom\u00e1ticos para c\u00e2ncer de pr\u00f3stata ou anormalidades que possam levar ao c\u00e2ncer de pr\u00f3stata, com o objetivo de encontrar c\u00e2nceres que possam ter alto risco de dissemina\u00e7\u00e3o se n\u00e3o forem tratados e de encontr\u00e1-los precocemente, antes que se disseminem.<sup>1<\/sup> O principal teste de rastreamento \u00e9 o exame de sangue do ant\u00edgeno prost\u00e1tico espec\u00edfico (PSA), frequentemente acompanhado de um exame de toque retal (TR).<sup>2<\/sup> O ant\u00edgeno prost\u00e1tico espec\u00edfico (PSA) \u00e9 uma enzima glicoproteica secretada pelo epit\u00e9lio secretor prost\u00e1tico e pelas ves\u00edculas seminais, sendo a prote\u00edna mais abundante no plasma seminal.<sup>3<\/sup> N\u00edveis elevados de PSA h\u00e1 muito tempo s\u00e3o associados \u00e0 malignidade prost\u00e1tica e constituem o elemento inicial fundamental do rastreamento, embora t\u00edtulos elevados de PSA n\u00e3o sejam espec\u00edficos do c\u00e2ncer de pr\u00f3stata.<sup>4<\/sup> As decis\u00f5es sobre o rastreamento devem ser individualizadas por meio da tomada de decis\u00e3o compartilhada entre o paciente e o profissional de sa\u00fade, ponderando os potenciais benef\u00edcios, riscos e incertezas do rastreamento, do diagn\u00f3stico e do tratamento.<sup>5<\/sup><\/p>","gt-synonyms":"Rastreio de PSA, rastreio do cancro da pr\u00f3stata, dete\u00e7\u00e3o precoce do cancro da pr\u00f3stata, teste de PSA, teste de antig\u00e9nio espec\u00edfico da pr\u00f3stata, dete\u00e7\u00e3o do cancro da pr\u00f3stata","gt-citation":"[1] US Preventive Services Task Force. Prostate Cancer: Screening. Final Recommendation Statement. May 8, 2018. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/prostate-cancer-screening\r\n\r\n[2] American Cancer Society. American Cancer Society Recommendations for Prostate Cancer Early Detection. Updated November 22, 2023. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/detection-diagnosis-staging\/acs-recommendations.html\r\n\r\n[3] Jain MA, Leslie SW, Sapra A. Prostate Cancer Screening. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556081\/\r\n\r\n[4] American Urological Association. Early Detection of Prostate Cancer: AUA\/SUO Guideline (2023). https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/early-detection-of-prostate-cancer-guidelines\r\n\r\n[5] Centers for Disease Control and Prevention. Should I Get Screened for Prostate Cancer? Updated January 29, 2025. https:\/\/www.cdc.gov\/prostate-cancer\/screening\/get-screened.html","gt-clinical-context":"<p>O rastreamento prost\u00e1tico tem indica\u00e7\u00e3o cl\u00ednica para homens com base na idade, nos fatores de risco e nas prefer\u00eancias individuais, ap\u00f3s uma tomada de decis\u00e3o compartilhada com os profissionais de sa\u00fade.<sup>1<\/sup> De acordo com a US Preventive Services Task Force (USPSTF), homens de 55 a 69 anos devem tomar decis\u00f5es individuais sobre a realiza\u00e7\u00e3o do rastreamento do c\u00e2ncer de pr\u00f3stata com o teste de PSA ap\u00f3s discutir os potenciais benef\u00edcios e danos com seu m\u00e9dico.<sup>2<\/sup> A USPSTF recomenda contra o rastreamento de rotina em homens com 70 anos ou mais.<sup>2<\/sup><\/p>\r\n<p>A American Cancer Society recomenda que os homens tenham a oportunidade de tomar uma decis\u00e3o informada, junto com seu profissional de sa\u00fade, sobre fazer ou n\u00e3o o rastreamento do c\u00e2ncer de pr\u00f3stata em diferentes idades, conforme os fatores de risco: aos 50 anos para homens com risco m\u00e9dio, aos 45 anos para homens com alto risco (incluindo homens afro-americanos e aqueles com um parente de primeiro grau diagnosticado com c\u00e2ncer de pr\u00f3stata antes dos 65 anos) e aos 40 anos para homens com risco ainda maior (aqueles com mais de um parente de primeiro grau que teve c\u00e2ncer de pr\u00f3stata em idade precoce).<sup>3<\/sup><\/p>\r\n<p>A American Urological Association (AUA) e a Society of Urologic Oncology (SUO) recomendam que os m\u00e9dicos pratiquem a tomada de decis\u00e3o compartilhada com as pessoas para as quais o rastreamento do c\u00e2ncer de pr\u00f3stata seria apropriado e procedam com base nos valores e prefer\u00eancias de cada pessoa.<sup>4<\/sup> Elas recomendam o uso do PSA como primeiro teste de rastreamento, com rastreamento regular a cada 2 a 4 anos para pessoas de 50 a 69 anos.<sup>4<\/sup> Para aqueles com risco aumentado (ascend\u00eancia negra, muta\u00e7\u00f5es germinativas, hist\u00f3rico familiar significativo), o rastreamento deve come\u00e7ar entre 40 e 45 anos.<sup>4<\/sup><\/p>\r\n<p>Os crit\u00e9rios de sele\u00e7\u00e3o de pacientes incluem a considera\u00e7\u00e3o da expectativa de vida (pelo menos 10 anos), dos fatores de risco (idade, ra\u00e7a\/etnia, hist\u00f3rico familiar) e dos valores do paciente em rela\u00e7\u00e3o aos potenciais benef\u00edcios e danos do rastreamento.<sup>5<\/sup> O processo de rastreamento normalmente envolve o teste de PSA, possivelmente seguido de exame de toque retal (TR) e, se indicado, testes adicionais de biomarcadores, exames de imagem (como resson\u00e2ncia magn\u00e9tica) e bi\u00f3psia de pr\u00f3stata.<sup>4<\/sup><\/p>\r\n<p>Os resultados esperados do rastreamento incluem a potencial redu\u00e7\u00e3o da mortalidade por c\u00e2ncer de pr\u00f3stata e da doen\u00e7a metast\u00e1tica por meio da detec\u00e7\u00e3o precoce, mas tamb\u00e9m o poss\u00edvel sobrediagn\u00f3stico e sobretratamento de c\u00e2nceres que nunca teriam causado sintomas ou morte.<sup>5<\/sup> Os potenciais danos do rastreamento incluem resultados falso-positivos que levam a procedimentos desnecess\u00e1rios, complica\u00e7\u00f5es decorrentes de procedimentos diagn\u00f3sticos (como infec\u00e7\u00e3o ap\u00f3s bi\u00f3psia) e efeitos colaterais do tratamento (incluindo incontin\u00eancia urin\u00e1ria, disfun\u00e7\u00e3o er\u00e9til e problemas intestinais).<sup>5<\/sup><\/p>","gt-related-evidence":null,"gt-featured":true,"gt-ai-referenced":false,"gt-view-count":102},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.7 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Rastreamento Prost\u00e1tico: PSA e Detec\u00e7\u00e3o Precoce | Rigicon<\/title>\n<meta name=\"description\" content=\"Guia sobre rastreamento prost\u00e1tico: PSA, toque retal e RM multiparam\u00e9trica. Quando iniciar, frequ\u00eancia e decis\u00e3o compartilhada. EAU 2025.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rastreamento Prost\u00e1tico - Prosthetic Urology Glossary\" \/>\n<meta property=\"og:description\" content=\"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-06T16:50:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/rastreamento-prostatico\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/rastreamento-prostatico\\\/\",\"name\":\"Rastreamento Prost\u00e1tico: PSA e Detec\u00e7\u00e3o Precoce | Rigicon\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\"},\"datePublished\":\"2025-07-10T13:16:47+00:00\",\"dateModified\":\"2026-10-06T16:50:55+00:00\",\"description\":\"Guia sobre rastreamento prost\u00e1tico: PSA, toque retal e RM multiparam\u00e9trica. Quando iniciar, frequ\u00eancia e decis\u00e3o compartilhada. EAU 2025.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/rastreamento-prostatico\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/rastreamento-prostatico\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/rastreamento-prostatico\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glossary Terms\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/urology-glossary\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Rastreamento Prost\u00e1tico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.com\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q141595822\"],\"description\":\"A Rigicon \u00e9 uma fabricante especializada, sediada nos EUA, de dispositivos de urologia prot\u00e9tica: pr\u00f3teses penianas, esf\u00edncteres urin\u00e1rios artificiais e pr\u00f3teses testiculares, comercializados em mais de 75 pa\u00edses.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rastreamento Prost\u00e1tico: PSA e Detec\u00e7\u00e3o Precoce | Rigicon","description":"Guia sobre rastreamento prost\u00e1tico: PSA, toque retal e RM multiparam\u00e9trica. Quando iniciar, frequ\u00eancia e decis\u00e3o compartilhada. EAU 2025.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/","og_locale":"pt_BR","og_type":"article","og_title":"Rastreamento Prost\u00e1tico - Prosthetic Urology Glossary","og_description":"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.","og_url":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","article_modified_time":"2026-10-06T16:50:55+00:00","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/","url":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/","name":"Rastreamento Prost\u00e1tico: PSA e Detec\u00e7\u00e3o Precoce | Rigicon","isPartOf":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#website"},"datePublished":"2025-07-10T13:16:47+00:00","dateModified":"2026-10-06T16:50:55+00:00","description":"Guia sobre rastreamento prost\u00e1tico: PSA, toque retal e RM multiparam\u00e9trica. Quando iniciar, frequ\u00eancia e decis\u00e3o compartilhada. EAU 2025.","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/rastreamento-prostatico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.rigicon.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Glossary Terms","item":"https:\/\/www.rigicon.com\/pt-br\/urology-glossary\/"},{"@type":"ListItem","position":3,"name":"Rastreamento Prost\u00e1tico"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/pt-br\/#website","url":"https:\/\/www.rigicon.com\/pt-br\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/pt-br\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.com\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/","https:\/\/www.wikidata.org\/wiki\/Q141595822"],"description":"A Rigicon \u00e9 uma fabricante especializada, sediada nos EUA, de dispositivos de urologia prot\u00e9tica: pr\u00f3teses penianas, esf\u00edncteres urin\u00e1rios artificiais e pr\u00f3teses testiculares, comercializados em mais de 75 pa\u00edses.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-term\/12678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-term"}],"about":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/types\/glossary-term"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/media?parent=12678"}],"wp:term":[{"taxonomy":"glossary-category","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-category?post=12678"},{"taxonomy":"glossary-product","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-product?post=12678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}